BOZEN, Italy--(EON: Enhanced Online News)--Health Robotics today reported that its 2nd Generation Sterile Compounding Robots continued to dominate the global IV Robotics market [particularly in the United States of America and Canada, with 3 i.v.STATION ONCO and 12 i.v.STATION Robots sold in 3Q2013], now surpassing a worldwide footprint of 500 installations under contract: http://www.health-robotics.com/en/installations/
North American sales accounted for 95% of Health Robotics’ new contract revenue, as the company expanded its worldwide success also within the US Federal Government, winning contract awards from both for the US Department of Defense [Nellis Air Force Base], and the US Department of Veteran Affairs (Michael DeBakey Medical Center]. Additionally, the company added to its prestigious USA customer base with Adventist Health Systems-Florida Hospital, Bronson Methodist, Confluence Health, Massachusetts General Hospital, Ochsner Health System, Oregon Health Sciences University, Pennsylvania Hospital, University of Iowa Health System, and University of Rochester Medical Center, amongst others.
Gaspar DeViedma, Health Robotics’ Executive Vice President and Board Member, stated: “Health Robotics has significantly outperformed all of its prior years’ results with 174 new contracts [52 Robots] YTD in 2013, compared to 79 new sales YTD in 2012. In Canada, Health Robotics won its first i.v.STATION ONCO tender award in the country, continuing its 100% winning record in Canadian Public Tenders over the competition. When given a choice in public tenders, Canadian hospital pharmacists continue to overwhelmingly favor i.v.STATION and i.v.STATION ONCO’s speed, price, and size advantages over available alternatives”.
With over 115 i.v.STATION platform 2nd Generation Robots and more than 200 i.v.SOFTs under contract worldwide, Health Robotics has now tripled the installations of its first generation  technology, including over 30 installations under contract for patient-specific HL7 interfaces to Epic, Cerner, Siemens, McKesson, Meditech, Allscripts, and other pharmacy information systems.
About Health Robotics:
Founded in 2006 and now reaching 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market], Health Robotics is the undisputed leading supplier of life-critical intravenous medication robots, providing more than 500 hospital installations in 5 continents with the only fully-integrated Robotics based technology, IV Workflow, and manual compounding software automation solutions. Health Robotics’ second generation products [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have been found [through scientific and peer-reviewed studies 1, 2, 3] to greatly contribute to ease hospitals’ growing pressures to improve patient safety1, increase throughput, and contain costs1, 3. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics’ medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug1 and diluent1 exchange errors, improve drug potency2, decrease other medical mistakes and sterility risks, work more efficiently1, 3, reduce waste and controlled substances’ diversion, reduce pharmacy technician upper-limb injuries3, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff.
1 Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs. Seger, Churchill, Keohane, Belisle, Wong, Sylvester, Chesnick, Burdick, Wien, Cotugno, Bates, and Rothschild. Brigham & Women’s Hospital, Massachusetts College of Pharmacy, and Harvard Medical School. Journal of Oncology Practice, Nov. 2012, Volume 8, number 6.
2 Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin®, Remicade®, and Herceptin®. Peters, Capelle, Arvinte, van de Garde. St. Antonius Hospital. mAbs January 2013, Volume 5, Issue 1.
3 Comparing the upper limb disorder risks associated with manual and automated cytotoxic compounding. McLeod, Zochowska, Leonard, Crow, Jacklin, Dean, Franklin. Imperial College Healthcare NHS Trust. European Journal of Hospital Pharmacy April 2012.